Detalles de la búsqueda
1.
Dynamic Profiling of the Immune Tumor Microenvironment in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy.
Oncology
; 101(7): 435-445, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37307799
2.
Concordance of microsatellite instability and mismatch repair status in paired biopsies and surgical specimens of resectable gastroesophageal adenocarcinoma: time for a call to action.
Gastric Cancer
; 26(6): 958-968, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37382783
3.
Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies.
Int J Clin Oncol
; 28(3): 363-369, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36689013
4.
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel.
Pharmacogenomics J
; 21(2): 233-242, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33462346
5.
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib.
Hepatol Res
; 51(7): 796-802, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34005839
6.
HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer.
Oncologist
; 25(10): 886-893, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32353192
7.
Immune Checkpoint Inhibitors in Esophageal Cancers: are we Finally Finding the Right Path in the Mist?
Int J Mol Sci
; 21(5)2020 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32121290
8.
Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer.
Br J Cancer
; 120(5): 522-526, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30745584
9.
Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies.
Int J Clin Oncol
; 28(3): 370, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36805385
10.
First-line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors.
Int J Cancer
; 139(4): 938-45, 2016 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27038273
11.
In Reply.
Oncologist
; 26(10): e1895-e1896, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34176190
12.
Second-line therapy for advanced pancreatic cancer: evaluation of prognostic factors and review of current literature.
Future Oncol
; 12(7): 901-8, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26883177
13.
Efficacy and safety of systemic chemotherapy for radically resectable esophago-gastric adenocarcinoma in older patients: A systematic review and meta-analysis.
J Geriatr Oncol
; 15(1): 101600, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37550170
14.
Abdominal Visceral-to-Subcutaneous Fat Volume Ratio Predicts Survival and Response to First-Line Palliative Chemotherapy in Patients with Advanced Gastric Cancer.
Cancers (Basel)
; 15(22)2023 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38001651
15.
Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study.
J Cancer Res Clin Oncol
; 149(9): 6601-6611, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36795195
16.
Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer.
Am J Cancer Res
; 12(7): 3347-3356, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35968330
17.
Targeted and immunotherapy in the era of personalised gastric cancer treatment.
Best Pract Res Clin Gastroenterol
; 50-51: 101738, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33975679
18.
Biomarkers related to fatty acid oxidative capacity are predictive for continued weight loss in cachectic cancer patients.
J Cachexia Sarcopenia Muscle
; 12(6): 2101-2110, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34636159
19.
Role of Baseline Computed-Tomography-Evaluated Body Composition in Predicting Outcome and Toxicity from First-Line Therapy in Advanced Gastric Cancer Patients.
J Clin Med
; 10(5)2021 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33807648
20.
Gemcitabine Plus Nab-Paclitaxel Induces PD-L1 mRNA Expression in Plasma-Derived Microvesicles in Pancreatic Cancer.
Cancers (Basel)
; 13(15)2021 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34359638